A new Heatmap article explores what sets us apart in the fusion industry: we’re already generating revenue. While other companies race toward net energy gain, we’ve been making money for years by selling neutrons for materials testing and medical isotopes for cancer therapy.
The article breaks down how our approach works — using particle accelerators to drive small-scale fusion reactions that produce high-energy neutrons without the complexity of a full power plant. These neutrons test turbine blades for F-35 jets, verify fission fuel, and will create medical isotopes worth billions per gram. As our founder and CEO Greg Piefer explains: “Commercial is important to us, and it always has been…. We won’t be first to Q>1, but we will be first to economics greater than one.”
By starting with high-value applications and building toward fusion power, we’re taking what Piefer calls “the fastest path to fusion commercialization for energy.”
Read the full piece to see how we’re proving fusion works commercially today.